Becher, Emulsions Theory and Practice, 2nd Edition, Chapter 5, (1965). |
Herbert, “The Mode of Action of Mineral-Oil Emulsion Adjuvants on Antibody Production in Mice,” Immunology 14:301-318 (1968). |
Kaufman et al., “Spectral Absorption Measurements for Determination of Ease of Formation and Stability of Oil in Water Emulsions,” J. Dispersion Science and Technology 24:475-490 (1981). |
Ott et al., Vaccine Design: The Subunit and Adxjuvant Approach, Chapter 10, Powell et al., Ed., Plenum Press, New York. |
Sanchez-Pescador et al., “The Effect of Adjuvants on the Efficacy of a Recombinant Herpes Simplex Virus Glycoprotein Vaccine,” J. Immunology 141:1720-1727 (1988). |
Silvestri et al., “Theoretical Evaluation of Dispersed Droplet Radii in Submicron Oil-in-Water Emulsions,” International Journal of Pharmaceutics 50(2):141-146 (1989). |
Singh et al., “Parenteral Emulsions as Drug Carrier Systems,” J. Parenteral Science & Technology 40(1):34-41 (1986). |
Woodard et al., “Stable Oil-in-Water Emulsions: Preparation and Use as Vaccine Vehicles for Lipophilic Adjuvants,” Vaccine 3:137-144 (1985). |
Yarkoni et al., “Influence of Type of Oil and Surfactant Concentration on the Efficacy of Emulsified Mycobacterium bovis BCG Cell Walls to Induce Tumor Regression in Guinea Pigs,” Infection and Immunity 28(3):881-886 (1980). |
Idson, “Pharmaceutical Emulsions”, in Pharmaceutical Dosage Forms, Disperse Systems, vol. 1, (Lieberman et al., eds.) Marcel Dekker, New York, 1988, pp. 199-243).* |
Remington's Pharmaceutical Science (Gennaro, ed.) Mack Publ. Co., Easton, PA. 1985, pp. 298-299, 317-329, and 1507-1511. |